Current Report Filing (8-k)
April 26 2017 - 06:36AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR
15(d) of The Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
April
26, 2017
Medidata
Solutions, Inc.
(Exact name of registrant as specified in
its charter)
Delaware
(State or other jurisdiction
of
incorporation)
|
001-34387
(Commission
File Number)
|
13-4066508
(IRS Employer
Identification No.)
|
350 Hudson Street, 9th Floor
New York, New York
(Address of principal executive
offices)
|
10014
(Zip Code)
|
Registrant’s telephone number, including area code:
(212)
918-1800
Not Applicable
(Former name or former address, if
changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth company
⃞
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act.
⃞
Item 2.02.
|
Results of Operations and Financial Condition.
|
On April 26, 2017, Medidata Solutions, Inc. issued a press release
announcing its financial results for the quarter ended March 31,
2017. A copy of the press release is furnished herewith as Exhibit
99.1, and is incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information
in this Current Report on Form 8-K, including the exhibits, shall not be
deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section, and shall not be
incorporated by reference into any registration statement or other
document filed under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
99.1
|
|
Press release issued by Medidata Solutions, Inc. on April 26, 2017,
furnished herewith.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
MEDIDATA SOLUTIONS, INC.
|
|
|
Date: April 26, 2017
|
|
|
|
|
By:
|
/s/ MICHAEL I. OTNER
|
|
Name:
|
Michael I. Otner
|
|
Title:
|
Executive Vice President, General Counsel and Secretary
|
EXHIBIT INDEX
Exhibit No.
|
|
Description
|
99.1
|
|
Press release issued by Medidata Solutions, Inc. on April 26,
2017, furnished herewith.
|
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2023 to Mar 2024